Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
August 9, 2019 | 10.4244/EIJ-D-19-00262
Showing 1-20 of 35 articles
Coronary interventions
BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial July 30, 2019 | 10.4244/EIJ-D-19-00566
Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention
June 11, 2019 | 10.4244/EIJ-D-19-00262
Coronary interventions
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial February 26, 2019 | 10.4244/EIJ-D-18-01000
Reply to the letter to the editor regarding the article “Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population”
February 7, 2019 | 10.4244/EIJ-D-18-00235R
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial
October 19, 2018 | 10.4244/EIJ-D-18-00336
Stents and scaffolds
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population October 12, 2018 | 10.4244/EIJ-D-17-01067
Is the proximal left anterior descending coronary artery segment justifiably considered as the last frontier for stenting?
September 20, 2018 | 10.4244/EIJV14I7A127
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
November 20, 2017 | 10.4244/EIJ-D-17-00634
Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis
November 20, 2017 | 10.4244/EIJ-D-17-00301
Coronary interventions
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III July 20, 2017 | 10.4244/EIJ-D-17-00254
Coronary interventions
First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis April 20, 2017 | 10.4244/EIJ-D-16-00975
Coronary interventions
Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial April 20, 2017 | 10.4244/EIJ-D-16-00571
Coronary interventions
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging August 5, 2016 | 10.4244/EIJV12I5A97
Coronary interventions
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial July 20, 2016 | 10.4244/EIJY15M08_01
Coronary interventions
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study April 20, 2016 | 10.4244/EIJY15M10_06
Coronary interventions
Oversized post-dilatation of current bioresorbable vascular scaffolds: kill or cure? March 18, 2016 | 10.4244/EIJV11I12A259
